Safety of Single and Repeat Dose of PYC-001 Eye Injections in People With Autosomal Dominant Optic Atrophy (Myrtle)

NCT06970106 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

OPA1 Gene Mutation
Autosomal Dominant Optic Atrophy
Hereditary Optic Atrophies
Kjer Optic Atrophy

Interventions

DRUG: PYC-001

Sponsor

PYC Therapeutics